Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease

Journal of Clinical Apheresis

Volumn 22, Issue 1, 2007, Pages 10-14

  Jhang, Jeffrey S ^a   Schilsky, Michael L ^b   Lefkowitch, Jay H ^a   Schwartz, Joseph ^a  

^a Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Copper; Hemolysis; Hepatolenticular; Liver failure

Indexed keywords

CITRIC ACID; COPPER; FRESH FROZEN PLASMA; GLUCONATE CALCIUM;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COPPER BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; LIVER TRANSPLANTATION; PHYSICAL EXAMINATION; PLASMAPHERESIS; PREOPERATIVE CARE; TREATMENT OUTCOME; URINARY EXCRETION; WILSON DISEASE;

ADULT; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 33947175068     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20118     Document Type: Article

References (23)

1. Chelly J, Monaco AP. Cloning the Wilson disease gene. Nat Genet 1993;5(4):317-318.
2. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, Devoto M, Peppercorn J, Bush AI, Sternlieb I, Pirastu M, Gusella JF, Evgrafov O, Penchaszadeh GK, Honig B, Edelman IS, Soares MB, Scheinberg IH, Gilliam TC. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.
3. Tao TY, Gitlin JD. Hepatic copper metabolism: insights from genetic disease. Hepatology 2003;37:1241-1247.
4. Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med 1977;86:301-303.
5. Forman SJ, Kumar KS, Redeker AG, Hochstein P. Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms. Am J Hematol 1980;9:269-275.
6. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583-587.
7. Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology 1984;4(1 Suppl):15S-17S.
8. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.
9. Emre S, Atillasoy EO, Ozdemir S, Schilsky M, Rathna Varma CV, Thung SN, Sternlieb I, Guy SR, Sheiner PA, Schwartz ME, Miller CM. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 2001;72:1232-1236.
10. Boulard M, Blume KG, Beutler E. The effect of copper on red cell enzyme activities. J Clin Invest 1972;51:459-461.
11. Hamlyn AN, Gollan JL, Douglas AP, Sherlock S. Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J 1977;2:660-662.
12. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology 1986;90:2004-2007.
13. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-1085.
14. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, Williams R, Jalan R. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002;8:962-967.
15. Kitazawa J, Kaizuka M, Kasai M, Noda Y, Takahashi Y, Terui K, Narumi S, Hakamada K, Sasaki M, Kamata Y, Endo T, Nomachi S, Saikai T, Mizoguchi Y, Kinebuchi M, Ito E, Matsuura A. Hemolytic crisis with fulminant hepatic failure in Wilson disease without consanguinity. Pediatr Int 2004;46:726-729.
16. Enomoto K, Ishibashi H, Irie K, Okumura Y, Nomura H, Fukushima M, Inaba S, Niho Y. Fulminant hepatic failure without evidence of cirrhosis in a case of Wilson's disease. Jpn J Med 1989;28:80-84.
17. Dabrowska E, Jablonska-Kaszewska I, Ozieblowski A, Falkiewicz B. Acute haemolytic syndrome and liver failure as the first manifestations of Wilson's disease. Med Sci Monit 2001; 7(Suppl 1):246-251.
18. Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, Benhamou JP, Valla D. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 2001;48:849-852.
19. Rodriguez Farina E, Tremosa Liurba G, Xiol Quingles X, Lores Obradors A, Castellote Alonso J, Gornals Soler JB, Lopez Nunez C. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease. Rev Esp Enferm Dig 2003;95:60-62,63-65.
20. Kiss JE, Herman D, Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson's disease. Transfusion 1998;38:327-331.
21. Sarles J, Lefevre P, Picon G. Plasma exchange for fulminant Wilson disease. Eur J Pediatr 1992;151:310.
22. Matsumura A, Hiraishi H, Terano A. Plasma exchange for hemolytic crisis in Wilson disease. Ann Intern Med 1999;131: 866.
23. Nagata Y, Uto H, Hasuike S, Ido A, Hayashi K, Eto T, Hamakawa T, Tanaka K, Tsubouchi H. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease. Intern Med 2003;42:967-970.